ONCOGENOMA Precision Oncology
Precision Oncology Specialists
The development of molecularly targeted drugs has made it possible to specifically treat the genetic characteristics of a tumor, improving the effectiveness of treatments.
Mutational Oncology
Precision Medicine
ONCOGENOME Precision Oncology UK is the Italian and European reference point for molecular diagnosis.
operates mainly as a diagnostic partner for genetic, cytogenetic and molecular analyses with the aim of providing
a complete service capable of satisfying the most diverse needs in the field of molecular diagnostics
Complete prevention service
- Specialist Oncology
- Specialist oncology visit
- Advanced Oncology Center
- Diagnosis and treatment of tumors
- Innovative oncological therapies
Request information
Analysis at the appearance of a tumor
- Personalized oncology medicine
- Targeted cancer therapies
- Tumor genomic profiling
- Molecular tests in oncology
Request information
Cutting-edge treatments
Oxygen-Ozone Therapy
- Ozone therapy and tumors
- Complementary treatments in oncology
- Oxygen therapy as oncological support
- Integrated therapies for cancer patients
Request information
Precision Oncology
We research the complete genomic profile of patient tumors to identify specific biomarkers and promote precision oncology in your city.
With the use of agnostic drugs, in oncology, this is an anticancer drug that is not specific for a particular type of tumor, but acts based on a specific molecular alteration or mutation present in the tumor, regardless of its origin. This means that the same drug can be used to treat different types of tumor if they share the same mutation.
Precision Oncology is a branch of oncology that focuses on the prevention, diagnosis, and treatment of tumors based on the specific molecular, genetic, epigenetic, and phenotypic characteristics of the individual patient and their tumor, rather than solely on the anatomical location or histology.
Precision Oncology is a medical approach that integrates:
- Genomic and molecular profiling of the tumor (e.g. somatic mutations, rearrangements, gene amplifications)
- Analysis of predictive and prognostic biomarkers
- Clinical data and individual characteristics of the patient
- Advanced technologies such as next-generation sequencing (NGS), liquid biopsy, and multi-omic analysis
in order to:
- Identify specific therapeutic targets
- Select targeted therapies or immunotherapies
- Reduce unnecessary toxicity
- Improving efficacy and survival
Key concept
We do not treat “lung cancer” or “breast cancer” in a generic sense, but rather the tumor with a specific molecular alteration (e.g. mutation of a specific oncogene) in that specific patient.
Objective
Maximizing clinical benefit through molecular stratification of patients, transforming the therapeutic approach from standardized to personalized and biologically driven.
Our specialists will contact you to discuss your case
Precision oncology is growing in Italy and represents a highly innovative area in cancer treatment, based on gene sequencing methods and molecularly targeted therapies. This approach involves personalized therapies, tailored to the specific characteristics of each patient and their tumor, with the goal of improving treatment efficacy and reducing side effects.
- Specialist Visits: Toll-Free Number: 800.019330
- Oncological Dermatology
- Breast Oncology Surgery
- Reconstructive Plastic Surgery
- General and Precision Oncology
- Second Opinion Oncology Visit
- Dermato-Oncological Surgery
Our Approach
If you do what you've done, you'll get what you've got. That's why we aim to develop revolutionary new treatment options to improve the lives of cancer patients.
Dr. Pasquale Adilardi MD
Dir. Sc. Oncogenoma Precision Oncology UK
We apply a patient care model that allows for a comprehensive approach, based on genetic information, clinical information, and tumor analysis using NGS technology.
This model allows us to approach patient care from a benefits perspective, thus achieving, through continuous patient monitoring, a significant reduction in adverse effects in oncology treatment.
Scope
We want to contribute to the quality of life of patients through timely and targeted care for each patient.
Experts
Our entire team of collaborators is focused on finding the best alternatives to support cancer patients in their various roles.
Technology
We use massive sequencing techniques to analyze patient samples, allowing us to gain a deeper understanding of their tumor. Discover over 3,000 genetic tests across 25 specialty areas.
Our services
We are experts in medical oncology, caring for patients with multiple tumors, both solid and hematological. Because when you're fighting cancer, you need treatment that offers the best possible outcome, tailored to your needs, and with minimal side effects to maintain your quality of life.